The IBA president recommends that NIH-funded scientists receiving compensation from industry accompany publication or other transmittal of their work with full disclosure of their sponsorship. In addition, he says, "it is not appropriate for scientists who are involved in clinical research to hold stock" in the companies involved. However, Godown says, for scientists conducting evaluative research, in which one course of treatment is compared with another, "the nexus is further removed," and, therefore, stock ownership should be permissible, "if there is full disclosure."
Association Briefs
As part of a new campaign to increase its visibility and impact, the 103-year-old honorary society Sigma Xi is heading south. The 110,000-member organization, with some 500 chapters and clubs around the country, has decided to sell its headquarters building in New Haven, Conn., and move to Research Triangle Park in North Carolina. "It's one of the most dynamic research milieus in the country," says society president Thomas Malone, "and it's got a can-do spirit that coincides with
Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
Interested in reading more?
Become a Member of
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Published In
Share
